AzTrials
AzTrials

Chronic PainNCT02903303

Hypnosis as a Potentiation Technique for the Interventional Treatment of Chronic Lumbar Pain

A study testing Hypnosis in people with Chronic Pain, run by Centre Hospitalier Universitaire Vaudois at 1 site in Switzerland.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This pilot study consists in testing the efficacy of hypnosis as an adjuvant treatment for patients suffering from chronic lumbar pain and for whom a facet block is indicated by a doctor in the Centre d'antalgie of CHUV (Centre Hospitalier Universitaire Vaudois), where this study will take place. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Chronic Pain
What is being tested?
Hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3 participants
Where
1 siteSwitzerland
Study dates
1 Jun 2016to 1 Sep 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Informed consent and signature of the declaration of consent ;
  • Patient suffering from chronic lumbar pain (> 3 months)
  • Indication for a facet block ;
  • Good ability to speak and understand French.

Who cannot join

  • Previous facet block for the same indication ;
  • Unability to understand or speak French ;
  • Unability to understand the written or oral instructions necessary to the protocol application ;
  • Acute or severe psychiatric decompensation and/or acute psychosocial distress ;
  • Complex psychosocial situation.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Centre d'antalgie, Centre Hospitalier Universitaire Vaudois

    Lausanne, Canton of Vaud, 1011

Other trials in Switzerland

About this study

Official title: Pilot Study : Hypnosis as a Potentiation Technique for the Interventional Treatment of Chronic Lumbar Pain

This pilot study consists in testing the efficacy of hypnosis as an adjuvant treatment for patients suffering from chronic lumbar pain and for whom a facet block is indicated by a doctor in the Centre d'antalgie of CHUV (Centre Hospitalier Universitaire Vaudois), where this study will take place. 5 to 8 patients will be included in this study. The goals of this study are :

  • Assess the feasibility of such a protocol with more patients
  • Measure the number of patients necessary to obtain a significant result
  • Search for possible side effects of the combination of both treatments
Read more

Every patient in this pilot study will undergo 4 hypnosis sessions within 2 weeks before the facet block. These sessions will be done with an hypnotherapist formed for this kind of treatment.

Three times during this study, each patient will have a discussion with the co-investigator :¨

  • 1st discussion : just before the first hypnosis session
  • 2nd discussion : after the 4 hypnosis sessions and just before the facet block, approximately 3 to 4 weeks after the 1st discussion
  • 3rd discussion : 2 to 4 weeks after the facet block

They will allow to obtain several data :

  • Pain assessment : intensity, localization, variability, characteristics, effects on daily life activities
  • Anxiety and depression assessment
  • Expectations assessment : about both treatments and their combination
  • Efficacy assessment : about both treatments for the patient
  • Questions about the perceptions of the treatments (prejudice, ...) et possible side effects.

These data will then be analysed (quantitative and qualitative analysis, depending on the question type) to fulfill the objectives of the study.

will include 5 to 8 people suffering from chronic lumbar pain. The procedure consists in two steps :

  1. 4 hypnosis sessions as an adjuvant treatment for number 2
  2. a facet block, which is the standard procedure in the Centre d'antalgie in CHUV.

There will be no control group, so every patient will participate to the hypnosis sessions and undergo the facet block. All the procedure of the facet block (including contraindications and side effects) are not considered to be part of this study because all patients in this study would have had a facet block if they would not participate in it.

The only data that will be collected are questionnaires about several items (pain, anxiety, depression, ...). These questionnaires are filled with the patient at the beginning of the study (day 0), before the facet block (between day 14 and day 21) and 2-4 weeks after it (between day 28 and day 49). There are quantitative and qualitative questions.

Conditions
Chronic Pain
Being tested
Hypnosis
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HypnosisOther

    It will consist in 4 hypnosis sessions within 2 weeks mainly for analgesic purpose. The main themes are :

    • 1st session : contact with the therapist, body scan, basic suggestions
    • 2nd session : hypnosis induction followed by suggestions tu build a safe place
    • 3rd session : it is the first complete hypnosis session (induction and specific suggestions against pain)
    • 4th session : very similar to the previous session for the content, focused on auto-hypnosis learning.
Study groups in NCT02903303
Study groupRoleWhat they receive
TreatmentOtherThere will be only one arm for this pilot study. All participants will follow 4 hypnosis sessions, and then the facet block.
Receives: Other: Hypnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Daily pain history

    During the first encounter (day 0), we will ask the patient since when he/she suffers from daily pain:

    • Daily pain in general since : < 3 months ; 3-6 months ; 6-12 months ; 1-3 years ; 3-5 years ; 5-10 years ; 10-20 years ; > 20 years
    • Daily lumbar pain since : < 6 months ; 6-12 months ; 1-3 years ; > 3 years

    Measured: 1st encounter with the co-investigator (day 0)

  2. Change in pain localization

    For this outcome, the patient is asked to say where is the daily pain and to precise if the pain concerns both sides. If there is more than one localization, the patient is asked to say which pain is the worst for him/her.

    Measured: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  3. Change in neuropathic characteristics of the lumbar pain

    Neuropathic characteristics (yes/no) :

    • burning
    • painful cold
    • electricity sensation
    • swarming
    • tingle
    • itching
    • numbness

    Measured: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  4. Change in lumbar pain intensity

    Intensity on a scale from 0 (no pain) to 10 (worst pain imaginable) :

    • Worst pain during the previous week
    • Lowest pain during the previous week
    • Average pain during the previous week

    Measured: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  5. Change in lumbar pain interferences

    For this outcome, we will ask the patient to tell us how much between 0 (no influence at all) and 10 (complete discomfort) the lumbar pain has on :

    1. General activity B) Mood C) Ability to walk D) Usual work E) Relationship with others F) Sleep G) Taste of living

    Measured: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  6. Change in Anxiety and Depression assessment

    In this pilot study, we will use the HADS scale (Hospital Anxiety and Depression Scale) to assess the level of anxiety and depression at the beginning of the study (day 0) and at the end of it (day 28-49). The items are the following (on a scale from 0 to 3, depending on the agreement to the sentence) :

    1. I feel tense and angry
    2. I am afraid, just like if something horrible was going to happen to me
    3. I'm worried
    4. I can sit quietly doing nothing and feel relaxed
    5. I experience feelings of fear and feel my stomach tensed
    6. I have ants in my pants and can't stay in place
    7. I experience sudden feelings of panic
    8. I feel the same pleasure to the same things as before
    9. I easily laugh and see things in a good way
    10. I am in a good mood
    11. I feel like I work slowly
    12. I don't take care about my appearance anymore
    13. I'm looking forward to doing some things
    14. I can enjoy a good book or a good TV/radio show

    Measured: 1st and 3rd encounters with the co-investigator (day 0, day 28-49)

  7. Presumed efficacy and expectations about treatments of lumbar pain

    On a scale from 0 (no efficacy at all) to 10 (completely relieves the pain), the patient assesses the presumed efficacy in general of : (only for the 1st encounter)

    1. Hypnosis alone
    2. Facet block alone
    3. Combination of both

    On a scale from 0 to 10, the patient assesses the expectations towards 1), 2) and 3).

    Measured: 1st encounter (day 0)

  8. Efficacy about treatments of lumbar pain

    On a scale from 0 (no efficacy at all) to 10 (completely relieves the pain), the patient assesses the efficacy of :

    1. Hypnosis alone
    2. Facet block alone
    3. Combination of both

    Measured: 3rd encounter (day 28-49)

  9. Functionality enhancement expectations thanks to hypnosis

    On a scale from 1 (minimal impact) to 5 (maximal enhancement), the patient assesses how much he/she thinks hypnosis will enhance the ability to :

    1. do sports
    2. practice the professional activity
    3. do your daily activities
    4. enhance your mood
    5. other (free space for the patient to write)

    Measured: 1st encounter (day 0)

  10. Functionality enhancement thanks to hypnosis

    On a scale from 1 (minimal impact) to 5 (maximal enhancement), the patient assesses how much hypnosis has enhanced his/her ability to :

    1. do sports
    2. practice the professional activity
    3. do your daily activities
    4. enhance your mood
    5. other (same item as in outcome 9)

    Measured: 3rd encounter (day 28-40)

  11. Questions with a qualitative analysis (part 1)

    During this encounter, we will ask questions to the patient and write down the main subjects mentioned, so that a theme-based analysis can be done with these. The questions are the following :

    • How do you think hypnosis work ?
    • What do you think will happen during hypnosis ?
    • Does it make you experience any emotions ?
    • What do you think of hypnosis as a therapeutical approach ?
    • How do you think facet block works ?
    • What do you think will happen during this intervention ?
    • What do you think of facet block as a therapeutical approach ?
    • What is your position about pain-relief drugs ?
    • Do you use other approaches against pain ? If yes, which one and what does and doesn't work with you ?
    • Do you have further comments about both treatments ?

    Measured: 1st encounter (day 0)

  12. Questions with a qualitative analysis (part 2)

    During this encounter, we will ask questions to the patient and write down the main subjects mentioned, so that a theme-based analysis can be done with these. The questions are the following :

    • How do you feel now about hypnosis as a treatment against pain ?
    • Did your mind change about hypnosis ? If yes, how and in what ?
    • Now, do you consider using hypnosis and/or self-hypnosis as a new way to deal with your lumbar pain ?
    • Do you have further comments about the study or the procedure ?

    Measured: 3rd encounter (day 28-49)

Secondary outcomes (1)
  1. Security assessment

    Immediately after the beginning of the study, every patient will be told to report every adverse effect or discomfort during or after an hypnosis session. During the hypnosis session, the therapist will be vigilant about possible negative effects and will help the patient go through it. He will also make a report about it.

    Every adverse effect will be discussed in detail with the patient during the 2nd or the 3rd discussion with the co-investigator.

    Measured: 2nd and 3rd encounters (day 14-21, day 24-49)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2016 (estimated)
  2. Study start1 Jun 2016
  3. Primary completion1 Sep 2016
  4. Study completion1 Sep 2016

Why it stopped: end of recruitment period

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
3 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02903303
Sponsor's protocol ID
2016-00236
Other IDs
2016
Status last verified
Aug 2021
First submitted
27 May 2016
Last updated
23 Aug 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
No: Participant data will remain accessible only for the people working in this study. However, the results will be shown in the context of a master degree in medicine of Mr Florent Schroeter.

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis in people with Chronic Pain, run by Centre Hospitalier Universitaire Vaudois at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 23 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: end of recruitment period). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Daily pain history (time frame: 1st encounter with the co-investigator (day 0)). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in